Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectin

Journal of Heart and Lung Transplantation

Volumn 32, Issue 6, 2013, Pages 641-650

  Franz, Marcus ^a,b   Hilger, Ingrid ^c   Grün, Katja ^a   Kossatz, Susanne ^c   Richter, Petra ^a   Petersen, Iver ^a   Jung, Christian ^a   Gummert, Jan ^d   Figulla, Hans R ^a   Kosmehl, Hartwig ^e   Neri, Dario ^b   Berndt, Alexander ^a   Renner, André ^d  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b ETH ZURICH   (Switzerland)

^c Institute of Diagnostic and Interventional Radiology i   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

cardiac allograft vasculopathy; chronic cardiac rejection; EDA + fibronectin; fibrosis; human antibodies; imaging

Indexed keywords

EDOXUDINE; FIBRONECTIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CARDIAC GRAFT REJECTION; CARDIAC IMAGING; CONTROLLED STUDY; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; HEART TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOOD VESSELS; FIBRONECTINS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MODELS, ANIMAL; MYOCARDIUM; OPTICAL IMAGING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, INBRED LEW; RNA SPLICE SITES; SPECTROSCOPY, NEAR-INFRARED;

EID: 84878000134     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.04.003     Document Type: Article

References (35)

1. J. Stehlik, L.B. Edwards, and A.Y. Kucheryavaya The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report - 2012 J Heart Lung Transplant 31 2012 1052 1064
2. G. Sarno, A. Lerman, and J.H. Bae Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition Nat Clin Pract Cardiovasc Med 6 2009 61 69
3. A.T. Armstrong, P.F. Binkley, and P.B. Baker Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation J Am Coll Cardiol 32 1998 704 710
4. M. Franz, D. Neri, and A. Berndt Chronic cardiac allograft rejection: critical role of ED-A(+) fibronectin and implications for targeted therapy strategies J Pathol 226 2012 557 561
5. A. Baldinger, B.R. Brehm, and P. Richter Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis Histochem Cell Biol 135 2011 427 441
6. M. Franz, A. Berndt, and K. Grun Expression of extra domain A containing fibronectin in chronic cardiac allograft rejection J Heart Lung Transplant 30 2011 86 94
7. A.J. Booth, S.C. Wood, and A.M. Cornett Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis J Pathol 226 2012 609 618
8. A. Villa, E. Trachsel, and M. Kaspar A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo Int J Cancer 122 2008 2405 2413
9. D. Berndorff, S. Borkowski, and S. Sieger Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate Clin Cancer Res 11 suppl 2005 7053s 7063ss
10. D. Neri, B. Carnemolla, and A. Nissim Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform Nat Biotechnol 15 1997 1271 1275
11. J.R. McCarthy, J. Bhaumik, and M.R. Karver Targeted nanoagents for the detection of cancers Mol Oncol 4 2010 511 528
12. M. Birchler, G. Neri, and L. Tarli Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers J Immunol Methods 231 1999 239 248
13. M. Santimaria, G. Moscatelli, and G.L. Viale Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer Clin Cancer Res 9 2003 571 579
14. K. Schwager, M. Kaspar, and F. Bootz Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis Arthritis Res Ther 11 2009 R142
15. K. Ono, and E.S. Lindsey Improved technique of heart transplantation in rats J Thorac Cardiovasc Surg 57 1969 225 229
16. H. Yokoyama, M. Ohmi, and S. Murata Proposal of a working left heart model with a heterotopic transplantation technique in rats J Heart Lung Transplant 14 1995 706 712
17. A. Renner, M.R. Sagstetter, and H. Harms Formation of 4-hydroxy-2-nonenal protein adducts in the ischemic rat heart after transplantation J Heart Lung Transplant 24 2005 730 736
18. V. Lange, A. Renner, and M. Sagstetter Cardiac allograft vasculopathy after cardiac transplantation and hormone therapy: positive effects? Transplantation 82 2006 234 240
19. S.S. Brack, M. Silacci, and M. Birchler Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C Clin Cancer Res 12 2006 3200 3208
20. E.M. Manders, J. Stap, and G.J. Brakenhoff Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy J Cell Sci 103 1992 857 862
21. J.R. Mansfield, C.C. Hoyt, and P.J. Miller Distinguished photons: increased contrast with multispectral in vivo fluorescence imaging BioTechniques 39 suppl 2005 S33 S37
22. M. Franz, P. Richter, and C. Geyer Mesenchymal cells contribute to the synthesis and deposition of the laminin-5 gamma2 chain in the invasive front of oral squamous cell carcinoma J Mol Histol 38 2007 183 190
23. A. Berndt, R. Kollner, and P. Richter A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies Histochem Cell Biol 133 2010 467 475
24. M. Franz, K. Grun, and P. Richter Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection Histochem Cell Biol 134 2010 503 517
25. R. Cale, M.J. Rebocho, and C. Aguiar Diagnosis, prevention and treatment of cardiac allograft vasculopathy Rev Portug Cardiol 31 2012 721 730
26. M. Ferencik, T.J. Brady, and U. Hoffmann Computed tomography imaging of cardiac allograft vasculopathy J Cardiovasc Comput Tomogr 6 2012 223 231
27. M. Weis, and W. von Scheidt Cardiac allograft vasculopathy: a review Circulation 96 1997 2069 2077
28. S.A. Hilderbrand, and R. Weissleder Near-infrared fluorescence: application to in vivo molecular imaging Curr Opin Chem Biol 14 2010 71 79
29. B.M. Tijink, L.R. Perk, and M. Budde (124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy Eur J Nucl Med Mol Imaging 36 2009 1235 1244
30. D.A. Heuveling, R. De Bree, and D.J. Vugts Phase 0 microdosing PET study using the human mini antibody F16SIP in head and neck cancer patients J Nucl Med 54 2013 397 401
31. N. Pasche, and D. Neri Immunocytokines: a novel class of potent armed antibodies Drug Discov Today 17 2012 583 590
32. G. Casi, and D. Neri Antibody-drug conjugates: basic concepts, examples and future perspectives J Control Rel 161 2012 422 428
33. C. Schliemann, and D. Neri Antibody-based vascular tumor targeting Recent Results Cancer Res. 180 2010 201 216
34. M. Pedretti, Z. Rancic, and A. Soltermann Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: three clinical-grade fully human antibodies Atherosclerosis 208 2010 382 389
35. M. Fiechter, K. Frey, and T. Fugmann Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies Atherosclerosis 214 2011 325 330